As Northwest BioScience (NWBO) is mentioned it sh
Post# of 148183
trial for DCVax is running for now almost 15 years.
Whatever the reasons for such a long time @ NWBO are, my questions :
Does a trial for GBM run always such a long (over-proportional) time and is it wise for CYDY to enter a trial that might consume immense ressources ?
Or is this something specific to the NWBO-approach (Dendritic-cells, like Dendreon a few years ago) and is there a realistic chance for CYDY to complete
their trials in a reasonable time-frame ?